Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Noncoding RNAs in gastric cancer: implications for drug resistance.

Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, Liu J, Xu Y, Shen Y, Yang M.

Mol Cancer. 2020 Mar 19;19(1):62. doi: 10.1186/s12943-020-01185-7. Review.

2.

Isoform Specific Effects of Mef2C during Direct Cardiac Reprogramming.

Wang L, Huang P, Near D, Ravi K, Xu Y, Liu J, Qian L.

Cells. 2020 Jan 22;9(2). pii: E268. doi: 10.3390/cells9020268.

3.

DACT2 modulated by TFAP2A-mediated allelic transcription promotes EGFR-TKIs efficiency in advanced lung adenocarcinoma.

Zhang N, Li Y, Xie M, Song Y, Liu J, Lei T, Shen Y, Yu J, Yang M.

Biochem Pharmacol. 2020 Feb;172:113772. doi: 10.1016/j.bcp.2019.113772. Epub 2019 Dec 20.

PMID:
31866302
4.

Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.

Chen J, Wang Z, Zhao J, Zhu S, Sun G, Liu J, Zhang H, Zhang X, Shen P, Shi M, Zeng H.

Sci Rep. 2019 Nov 29;9(1):17985. doi: 10.1038/s41598-019-54261-4.

5.

Multistage Polymerization Design for g-C3N4 Nanosheets with Enhanced Photocatalytic Activity by Modifying the Polymerization Process of Melamine.

Zhang C, Liu J, Huang X, Chen D, Xu S.

ACS Omega. 2019 Oct 14;4(17):17148-17159. doi: 10.1021/acsomega.9b01510. eCollection 2019 Oct 22.

6.

The value of transperineal apical prostate biopsy in predicting urethral/apical margin status after radical prostatectomy.

Dai J, Zhang X, Zhao J, Sun G, Chen J, Liu J, Tao R, Zeng H, Shen P.

Medicine (Baltimore). 2019 Oct;98(43):e17633. doi: 10.1097/MD.0000000000017633.

7.

Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.

Huang P, Wang L, Li Q, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Liu J, Qian L, Yang Y.

Stem Cell Res Ther. 2019 Oct 10;10(1):300. doi: 10.1186/s13287-019-1353-3.

8.

Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?

Wu T, Zhao J, Liu Z, Shen P, Zhang M, Sun G, Liu J, Liao B, Chen J, Zhu S, Dai J, Wang Z, Zhang H, Zhao P, Zhang X, Zhu X, Ni Y, Chen N, Zeng H.

Prostate. 2019 Oct;79(14):1673-1682. doi: 10.1002/pros.23892. Epub 2019 Aug 21.

PMID:
31433509
9.

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma.

Sun G, Zhang X, Liu Z, Zhu S, Shen P, Zhang H, Zhang M, Chen N, Zhao J, Chen J, Liu J, Dai J, Wang Z, Zhu X, Wang Y, Zeng H.

Neoplasia. 2019 Sep;21(9):921-931. doi: 10.1016/j.neo.2019.07.004. Epub 2019 Aug 8.

10.

Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.

Tian XQ, Yang YJ, Li Q, Xu J, Huang PS, Xiong YY, Li XD, Jin C, Qi K, Jiang LP, Chen GH, Qian L, Liu J, Geng YJ.

Am J Transl Res. 2019 Jul 15;11(7):4214-4231. eCollection 2019.

11.

Platelet-lymphocyte ratio as a potential prognostic factor in gynecologic cancers: a meta-analysis.

Jiang S, Liu J, Chen X, Zheng X, Ruan J, Ye A, Zhang S, Zhang L, Kuang Z, Liu R.

Arch Gynecol Obstet. 2019 Oct;300(4):829-839. doi: 10.1007/s00404-019-05257-y. Epub 2019 Aug 5. Review.

PMID:
31385023
12.

The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective study.

Liu J, Zhao J, Zhang M, Chen N, Sun G, Yang Y, Zhang X, Chen J, Shen P, Shi M, Zeng H.

Cancer Manag Res. 2019 Jul 12;11:6521-6529. doi: 10.2147/CMAR.S196286. eCollection 2019.

13.

AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy.

Zhao J, Zhang M, Liu J, Liu Z, Shen P, Nie L, Guo W, Cai D, Liu J, Armstrong CM, Sun G, Chen J, Zhu S, Dai J, Zhang H, Zhao P, Zhang X, Yin X, Zhu X, Ni Y, Chen N, Zeng H.

Prostate. 2019 Sep;79(13):1553-1562. doi: 10.1002/pros.23875. Epub 2019 Jul 11.

PMID:
31294486
14.

Single-Cell Transcriptomic Analyses of Cell Fate Transitions during Human Cardiac Reprogramming.

Zhou Y, Liu Z, Welch JD, Gao X, Wang L, Garbutt T, Keepers B, Ma H, Prins JF, Shen W, Liu J, Qian L.

Cell Stem Cell. 2019 Jul 3;25(1):149-164.e9. doi: 10.1016/j.stem.2019.05.020. Epub 2019 Jun 20.

PMID:
31230860
15.

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma.

Zhang X, Yin X, Zhang H, Sun G, Yang Y, Chen J, Zhu X, Zhao P, Zhao J, Liu J, Chen N, Wang J, Shen P, Zeng H.

BMC Cancer. 2019 Apr 16;19(1):360. doi: 10.1186/s12885-019-5578-4.

16.

What's in a cardiomyocyte - And how do we make one through reprogramming?

Keepers B, Liu J, Qian L.

Biochim Biophys Acta Mol Cell Res. 2020 Mar;1867(3):118464. doi: 10.1016/j.bbamcr.2019.03.011. Epub 2019 Mar 25. Review.

PMID:
30922868
17.

Vortex Dynamics in Trabeculated Embryonic Ventricles.

Battista NA, Douglas DR, Lane AN, Samsa LA, Liu J, Miller LA.

J Cardiovasc Dev Dis. 2019 Jan 22;6(1). pii: E6. doi: 10.3390/jcdd6010006.

18.

The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.

Zhao J, Liu J, Sun G, Zhang M, Chen J, Shen P, Liu Z, Liao B, Zhang X, Gong J, Chen N, Zeng H; Collaborators.

J Urol. 2019 Apr;201(4):759-768. doi: 10.1016/j.juro.2018.10.016.

PMID:
30652989
19.

Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis.

Ma H, Yu S, Liu X, Zhang Y, Fakadej T, Liu Z, Yin C, Shen W, Locasale JW, Taylor JM, Qian L, Liu J.

Circulation. 2019 Apr 2;139(14):1725-1740. doi: 10.1161/CIRCULATIONAHA.118.037803.

20.

The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysis.

Chen J, Zhang X, Sun G, Zhao J, Liu J, Zhao P, Dai J, Shen P, Zeng H.

Onco Targets Ther. 2018 Dec 13;11:9061-9070. doi: 10.2147/OTT.S187239. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center